Abstract
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), characterized by the accumulation of triglycerides in hepatocytes, is a manifestation of metabolic syndrome and has an increasing incidence worldwide. This condition predisposes individuals to the development of fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Among the events preceding carcinogenesis in HCC, the in…